New registry hopes to unlock secrets of rare breast cancer
NCT ID NCT05964504
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study is creating a registry for people with a rare type of breast cancer called invasive lobular carcinoma that has spread. Researchers will collect data from about 12 participants to develop a new tool that better measures how well treatments are working. The goal is to improve survival by understanding this cancer better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOBULAR BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
University of California, San Diego
RECRUITINGSan Diego, California, 92053, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94122, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Could a personal coach at home boost energy for cancer patients?
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a Four-Drug cocktail tame a tough breast cancer?
- Can a new drug outsmart resistant breast cancer?